StickIt Technologies announced leadership changes including the appointment of Dr. Adi Zuloff-Shani as CEO and two new independent board members to strengthen governance. The company restructured $617,000 of insider debt to $380,000, easing financial pressure, and raised CAD $722,100 through a private placement to fund operations and commercial expansion. StickIt also updated its intellectual property portfolio, maintaining a US patent for its cannabinoid and plant extract delivery technologies, and plans to grow via joint ventures in legal cannabis markets worldwide.
StickIt Technologies corporate update is presented here with a snapshot of the Health sector on Pluang as of Sep 18, 2026 03:42 WIB. Among 91 priced US Health-sector stocks, 60 advanced and 30 declined. Notable movers include Inovio Pharmaceuticals Inc (INO) at USD 1.22 with a 5.65% gain and 84% buy order activity, 10X Genomics Inc (TXG) at USD 76.66 up 5.48% with 100% buy orders, and Cassava Sciences Inc (FLNA) at USD 0.72 rising 5.23% with full buy interest.
Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...
Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
The Liquid Network hacker reportedly retains 598.5 BTC after a major exploit, even as about 3,400 BTC was recovered following a security patch. The L-BTC-to-Bitcoin conversion channel has been suspended for 11 days, blocking users from redeeming Liqu...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
